Silva C, Erickson-Beltran M
ACS Omega. 2022; 7(3):2649-2660.
PMID: 35097263
PMC: 8793083.
DOI: 10.1021/acsomega.1c04989.
Bettinger J, Ghaemmaghami S
Prion. 2020; 14(1):193-205.
PMID: 32744136
PMC: 7518762.
DOI: 10.1080/19336896.2020.1796898.
Shah S, Zhao D, Hussain T, Sabir N, Mangi M, Yang L
Front Mol Neurosci. 2018; 11:310.
PMID: 30337853
PMC: 6180192.
DOI: 10.3389/fnmol.2018.00310.
Elmallah M, Borgmeyer U, Betzel C, Redecke L
Prion. 2013; 7(5):404-11.
PMID: 24121542
PMC: 4134345.
DOI: 10.4161/pri.26745.
Younan N, Nadal R, Davies P, Brown D, Viles J
J Biol Chem. 2012; 287(34):28263-75.
PMID: 22654104
PMC: 3436581.
DOI: 10.1074/jbc.M112.354779.
Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein.
Wolschner C, Giese A, Kretzschmar H, Huber R, Moroder L, Budisa N
Proc Natl Acad Sci U S A. 2009; 106(19):7756-61.
PMID: 19416900
PMC: 2674404.
DOI: 10.1073/pnas.0902688106.
Recent advances in prion chemotherapeutics.
Sim V, Caughey B
Infect Disord Drug Targets. 2009; 9(1):81-91.
PMID: 19200018
PMC: 3347484.
DOI: 10.2174/1871526510909010081.
Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
OSullivan D, Jones C, Abdelraheim S, Brazier M, Toms H, Brown D
Protein Sci. 2009; 18(2):410-23.
PMID: 19173221
PMC: 2708060.
DOI: 10.1002/pro.44.
UV-light exposed prion protein fails to form amyloid fibrils.
Thakur A, Rao C
PLoS One. 2008; 3(7):e2688.
PMID: 18628989
PMC: 2442654.
DOI: 10.1371/journal.pone.0002688.
Genes contributing to prion pathogenesis.
Tamguney G, Giles K, Glidden D, Lessard P, Wille H, Tremblay P
J Gen Virol. 2008; 89(Pt 7):1777-1788.
PMID: 18559949
PMC: 2828448.
DOI: 10.1099/vir.0.2008/001255-0.
NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility.
OSullivan D, Jones C, Abdelraheim S, Thompsett A, Brazier M, Toms H
Biochem J. 2006; 401(2):533-40.
PMID: 16958619
PMC: 1820806.
DOI: 10.1042/BJ20060668.
Recombinant prion protein does not possess SOD-1 activity.
Jones S, Batchelor M, Bhelt D, Clarke A, Collinge J, Jackson G
Biochem J. 2005; 392(Pt 2):309-12.
PMID: 16156720
PMC: 1316266.
DOI: 10.1042/BJ20051236.
A copper(I) protein possibly involved in the assembly of CuA center of bacterial cytochrome c oxidase.
Banci L, Bertini I, Ciofi-Baffoni S, Katsari E, Katsaros N, Kubicek K
Proc Natl Acad Sci U S A. 2005; 102(11):3994-9.
PMID: 15753304
PMC: 554794.
DOI: 10.1073/pnas.0406150102.
Inactivation of Bacillus stearothermophilus leucine aminopeptidase II by hydrogen peroxide and site-directed mutagenesis of methionine residues on the enzyme.
Kuo L, Hwang G, Yang S, Hua Y, Chen W, Lin L
Protein J. 2004; 23(4):295-302.
PMID: 15214500
DOI: 10.1023/b:jopc.0000027854.56051.e4.
Copper-dependent functions for the prion protein.
Brown D, Sassoon J
Mol Biotechnol. 2002; 22(2):165-78.
PMID: 12405264
DOI: 10.1385/MB:22:2:165.
The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
Perry G, Sayre L, Atwood C, Castellani R, Cash A, Rottkamp C
CNS Drugs. 2002; 16(5):339-52.
PMID: 11994023
DOI: 10.2165/00023210-200216050-00006.
Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti G, Schweiger A, Glockshuber R, Van Doorslaer S
Biophys J. 2001; 81(1):516-25.
PMID: 11423433
PMC: 1301530.
DOI: 10.1016/S0006-3495(01)75718-9.
Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein.
Requena J, Groth D, Legname G, Stadtman E, Prusiner S, Levine R
Proc Natl Acad Sci U S A. 2001; 98(13):7170-5.
PMID: 11404462
PMC: 34641.
DOI: 10.1073/pnas.121190898.
Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
Gill A, RITCHIE M, Hunt L, Steane S, Davies K, Bocking S
EMBO J. 2000; 19(20):5324-31.
PMID: 11032800
PMC: 314005.
DOI: 10.1093/emboj/19.20.5324.
Consequences of manganese replacement of copper for prion protein function and proteinase resistance.
Brown D, Hafiz F, Glasssmith L, Wong B, Jones I, Clive C
EMBO J. 2000; 19(6):1180-6.
PMID: 10716918
PMC: 305659.
DOI: 10.1093/emboj/19.6.1180.